RSV and the Heart

Module inclusions

  • High quality video featuring leading experts
  • Supporting educational and sponsor resources
  • Digital certificate on completion
  • Set your own pace – the system remembers where you left off

How to access

Free. Click the orange button to access this course when you’ve logged in.

CPD outcomes

Educational Activities (EA)

1 hour

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
1 hour 

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 hours 

These are activities that require reflection on feedback about your work.

MO
0 hours 

These are activities that use your work data to ensure quality results.

Healthed brings together four leading experts in infectious disease, cardiology, geriatrics and diabetes for a lively, authoritative, cross disciplinary discussion.

For medical practitioners, it is critical to monitor cardiovascular function in patients with RSV infection, especially those with known heart disease or at high risk of cardiovascular complications. Management should ideally be multidisciplinary, involving both cardiologists and pulmonologists to address the complex interplay between respiratory and cardiovascular systems during an RSV infection.

This high-powered panel will provide many useful clinical insights that GPs will find invaluable as they come to understand the significance of RSV and the potential of the new vaccines to improve health outcomes.

Expert Panel

  • Prof Andrew Sindone, Cardiologist
  • Prof Dominic Dwyer, Infectious Disease Physician
  • Dr Desmond Graham, Geriatrician
  • Dr Ted Wu, Endocrinologist

 
This activity is proudly supported by an independent educational grant from GSK. July 2024.

Share this

Recent Articles